Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ming Hing Pharmaceutical is a long-established pharmaceutical company based in Hong Kong, founded in 1965. The company specializes in the manufacturing, wholesale, and distribution of a wide array of healthcare products, including Western medicines, Traditional Chinese Medicines (TCM), and health supplements. Operating from a GMP-certified facility, Ming Hing produces various dosage forms such as tablets, capsules, and topical medicated oils under its proprietary brands like Double Swallow. In addition to its own product lines, the company provides contract manufacturing (CMO) services and maintains a significant presence in the Southeast Asian over-the-counter (OTC) market. Their portfolio is primarily focused on accessible treatments for pain management, respiratory health, and digestive wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ming Hing Pharmaceutical.